Inventory |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Inventory Disclosure [Abstract] | |
| Inventory | 3. Inventory Inventory of $189,000 as of December 31, 2025, nil at December 31, 2024, consists of RenovoCath finished goods manufactured under contract by the Company’s third-party RenovoCath manufacturer. Inventory expected to be sold more than twelve months from the balance sheet date is classified as inventory, non-current on the balance sheets. Given the early stages of the Company’s commercialization strategy, there were no reserves for inventory, and no inventory was classified as non-current as of December 31, 2025. |